<p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">香港大學(xué)（港大）歡迎香港特區(qū)政府23日宣布指定李嘉誠醫(yī)學(xué)院為大灣區(qū)國際臨床試驗(yàn)研究所（GBAICTI）的營運(yùn)機(jī)構(gòu)。大灣區(qū)醫(yī)藥創(chuàng)新研究院位于河套深港科技創(chuàng)新合作區(qū)香港園區(qū)，計(jì)劃于今年第四季開始運(yùn)營，旨在成為具有全球影響力的創(chuàng)新臨床研究平臺(tái)，吸引內(nèi)地和跨國制藥機(jī)構(gòu)參與。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; font-size: 1.4em;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://info.compassedu.hk/sucai/content/1728447527339/1728447527339.jpg" width="773" height="544" /></p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;"><strong style="box-sizing: border-box; border-width: 0px; font-style: inherit; font-weight: 800; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px;">一站式臨床試驗(yàn)支援平臺(tái)</strong></p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;"><br style="box-sizing: border-box;" />港大校長張翔教授感謝政府以公開招標(biāo)方式委任港大醫(yī)學(xué)院為大灣區(qū)資訊科技平臺(tái)的營辦機(jī)構(gòu)。香港大學(xué)一直致力推動(dòng)創(chuàng)新，同時(shí)堅(jiān)定不移地追求卓越的學(xué)術(shù)成就和知識(shí)創(chuàng)造。去年10月《行政長官施政報(bào)告2023》宣布，政府將于今年年底前在河套深港科技創(chuàng)新合作區(qū)香港公園設(shè)立大灣區(qū)臨床試驗(yàn)支持平臺(tái)，為醫(yī)學(xué)研究機(jī)構(gòu)提供一站式臨床試驗(yàn)支持平臺(tái)。港大醫(yī)學(xué)院很榮幸被選為大灣區(qū)資訊科技計(jì)劃的營辦機(jī)構(gòu)。憑借高端醫(yī)學(xué)專業(yè)知識(shí)和創(chuàng)新醫(yī)學(xué)研究，港大醫(yī)學(xué)院將為香港成為國際創(chuàng)新科技中心作出貢獻(xiàn)，從而更好地融入國家發(fā)展大局。這也將完全符合大學(xué)的使命，即為香港、國家和世界做出有影響力的貢獻(xiàn)。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">港大醫(yī)學(xué)院院長劉澤星教授表示，港大醫(yī)學(xué)院獲委以重任，令他感到十分興奮。他說：「香港在上游基礎(chǔ)科學(xué)研究和醫(yī)學(xué)生物科技方面的優(yōu)勢顯而易見?！埂父鄞筢t(yī)學(xué)院和社會(huì)的期望是推動(dòng)本地研究成果轉(zhuǎn)化為適用的醫(yī)療解決方案。過去 30 年，我在香港從事醫(yī)療保健教育和醫(yī)學(xué)研究，我很高興見證香港臨床研究體系的這一新里程碑。我們將竭盡所能，與政府、學(xué)術(shù)界、業(yè)界、全球研究機(jī)構(gòu)和香港市民合作，以善用研究所的策略性發(fā)展。我們將統(tǒng)籌整合香港的公私營臨床試驗(yàn)資源，推動(dòng)建立一站式臨床試驗(yàn)支持平臺(tái)。我們的工作重點(diǎn)是提高臨床試驗(yàn)的能力、效率、規(guī)模和認(rèn)可度，并促進(jìn)先進(jìn)生物制藥、疫苗、中藥、醫(yī)療器械、診斷技術(shù)和各種療法的研究、開發(fā)和創(chuàng)新應(yīng)用，造?；颊?。我們的目標(biāo)是將香港定位為領(lǐng)先的國際健康和醫(yī)療創(chuàng)新中心。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; font-size: 1.4em;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://info.compassedu.hk/sucai/content/1728447589478/1728447589478.jpg" width="799" height="534" /></p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">港大醫(yī)學(xué)院副院長（研究）謝志豪教授補(bǔ)充：「港大醫(yī)學(xué)院一直致力進(jìn)行臨床試驗(yàn)。經(jīng)過嚴(yán)格的招標(biāo)程序后，我們獲政府委任營運(yùn)該研究所，這是對(duì)我們多年來臨床試驗(yàn)工作的認(rèn)可和信任，我們深感榮幸。香港有條件成為世界領(lǐng)先的醫(yī)療創(chuàng)新平臺(tái)。我們將不遺余力地加強(qiáng)人才培訓(xùn)，以及相關(guān)領(lǐng)域的科研合作和轉(zhuǎn)化，為香港和國家的醫(yī)療發(fā)展和長遠(yuǎn)規(guī)劃做出更大的貢獻(xiàn)?！?lt;/p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">劉澤星教授<strong style="box-sizing: border-box; border-width: 0px; font-style: inherit; font-weight: 800; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px;">指出</strong>，國家《十四五規(guī)劃綱要》明確支持香港作為國際創(chuàng)新科技中心的角色，而中國共產(chǎn)黨第二十屆中央委員會(huì)第三次全體會(huì)議強(qiáng)調(diào)深化改革，推動(dòng)中國式現(xiàn)代化。大灣區(qū)資訊科技研究院的成立為促進(jìn)香港和深圳之間的合作提供了獨(dú)特的機(jī)會(huì)，從而加快了研究成果和醫(yī)學(xué)進(jìn)步的實(shí)施。這項(xiàng)合作將有助香港融入國家發(fā)展大局，繼續(xù)發(fā)光發(fā)熱。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">劉教授表示，河套深港科技創(chuàng)新合作區(qū)香港園為醫(yī)療發(fā)展提供了理想的環(huán)境，將香港高質(zhì)素的國際臨床研究專業(yè)知識(shí)與深圳和大灣區(qū)其他地區(qū)廣泛的臨床網(wǎng)絡(luò)相結(jié)合。該項(xiàng)目將促進(jìn)港深兩地的跨境合作，建立符合國家和國際標(biāo)準(zhǔn)的臨床試驗(yàn)平臺(tái)，有望吸引跨國制藥公司進(jìn)駐擁有8000多萬人口的大灣區(qū)。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">港大醫(yī)學(xué)院臨床試驗(yàn)中心院長梁偉強(qiáng)教授善<strong style="box-sizing: border-box; border-width: 0px; font-style: inherit; font-weight: 800; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px;">用香港醫(yī)療優(yōu)勢推動(dòng)經(jīng)濟(jì)轉(zhuǎn)型</strong><br style="box-sizing: border-box;" />，他指出，香港的生物醫(yī)藥發(fā)展有賴政府主導(dǎo)的長遠(yuǎn)發(fā)展計(jì)劃。最近的一項(xiàng)舉措是今年 6 月成立香港醫(yī)療產(chǎn)品監(jiān)管中心籌備辦公室，其目的是為建立藥品和醫(yī)療器械監(jiān)管中心提出建議，并推進(jìn)這些產(chǎn)品的&ldquo;初步評(píng)估&rdquo;方法。另一項(xiàng)舉措是去年 11 月推出的新藥品注冊(cè)&ldquo;1+&rdquo;機(jī)制，該機(jī)制對(duì)于推進(jìn)該地區(qū)的醫(yī)療格局至關(guān)重要。另一項(xiàng)于 2020 年頒布的舉措允許粵港澳大灣區(qū)的指定醫(yī)療機(jī)構(gòu)在獲得廣東省當(dāng)局批準(zhǔn)后使用在香港注冊(cè)的藥品和醫(yī)療器械。這些努力不僅將使香港的患者受益，而且將使大灣區(qū)其他地區(qū)及其他地區(qū)的患者受益</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">&nbsp;</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;"><strong style="box-sizing: border-box; border-width: 0px; font-style: inherit; font-weight: 800; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px;">港大醫(yī)學(xué)院卓越的臨床研究</strong>先驅(qū)<br style="box-sizing: border-box;" />港大醫(yī)學(xué)院站在高質(zhì)量和創(chuàng)新醫(yī)學(xué)研究的前沿，將突破性的研究成果無縫轉(zhuǎn)化為必要的臨床服務(wù)。香港大學(xué)臨床試驗(yàn)中心（HKU-CTC）成立于 1998 年，現(xiàn)已成為亞洲和全球首屈一指的學(xué)術(shù)臨床研究機(jī)構(gòu)之一，擁有全面的結(jié)構(gòu)和提供一站式專業(yè)服務(wù)。它專注于推動(dòng)流程創(chuàng)新和研究戰(zhàn)略，使其在全球格局中脫穎而出。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;">過去 26 年，香港大學(xué)臨床試驗(yàn)中心促成了 2,000 多個(gè)研究項(xiàng)目，在癌癥治療、神經(jīng)科學(xué)、心血管疾病、乙型肝炎治療和臨床免疫學(xué)等關(guān)鍵領(lǐng)域取得了重大突破。值得注意的是，在 COVID-19 大流行期間，港大醫(yī)學(xué)院與中國大陸的機(jī)構(gòu)合作，迅速開發(fā)了一種鼻內(nèi) Covid-19 疫苗，該疫苗獲得了中國政府的緊急使用批準(zhǔn)。</p> <p style="box-sizing: border-box; border-width: 0px; font-stretch: inherit; line-height: 1.8; font-family: roboto, Arial, sans-serif, 'Microsoft JhengHei revise', 'Microsoft JhengHei', MingLiU; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px 0px 20px; color: #333333; white-space: normal; background-color: #ffffff; text-align: justify; font-size: 1.4em;"><span style="box-sizing: border-box;">2021 年，港大醫(yī)學(xué)院獲得政府資助成立五個(gè) InnoHK 創(chuàng)新香港研發(fā)平臺(tái)，包括免疫學(xué)及感染學(xué)中心 （C2i）、病毒學(xué)、疫苗學(xué)及治療學(xué)中心 （CVVT）、腫瘤學(xué)及免疫學(xué)中心 （COI）、轉(zhuǎn)化干細(xì)胞生物學(xué)中心 （CTSCB） 和健康數(shù)據(jù)發(fā)現(xiàn)實(shí)驗(yàn)室 （D</span><sup style="box-sizing: border-box; border-width: 0px; font-style: inherit; font-weight: inherit; font-stretch: inherit; font-size: 0.8em; line-height: 0; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; vertical-align: baseline; margin: 0px; padding: 0px; position: relative; top: -0.5em;">2</sup><span style="box-sizing: border-box;">4H）. 這些平臺(tái)利用大數(shù)據(jù)和人工智能技術(shù)來創(chuàng)造創(chuàng)新療法并推動(dòng)臨床醫(yī)學(xué)發(fā)展。</span></p>